J. M. A. Lange

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96‐week outcomes of HIV‐NAT 009

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, HIV medicine.